Trial intelligence / Profile preview

RORA: Rosuvastatin in Rheumatoid Arthritis

NCT00679510Phase 3Completed

Sponsor
University of Dundee
Start
Feb 2004
Primary completion
Jan 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of rosuvastatin in cardiovascular diseases (CVD), sponsored by University of Dundee. Started Feb 2004; status: completed.

02

Drugs

rosuvastatin
03

Conditions

cardiovascular diseases (CVD)

Beyond the preview

Go deeper on NCT00679510.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00679510.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call